Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0VQ3O
|
|||
Former ID |
DNC013516
|
|||
Drug Name |
1-(oxazol-2-yl)-3-(4-phenoxyphenyl)propan-1-one
|
|||
Synonyms |
CHEMBL441735
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C18H15NO3
|
|||
Canonical SMILES |
C1=CC=C(C=C1)OC2=CC=C(C=C2)CCC(=O)C3=NC=CO3
|
|||
InChI |
1S/C18H15NO3/c20-17(18-19-12-13-21-18)11-8-14-6-9-16(10-7-14)22-15-4-2-1-3-5-15/h1-7,9-10,12-13H,8,11H2
|
|||
InChIKey |
LLQSCQSWBWHWLL-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
BioCyc | Anandamide degradation | |||
KEGG Pathway | Retrograde endocannabinoid signaling | |||
Panther Pathway | Anandamide degradation |
References | Top | |||
---|---|---|---|---|
REF 1 | Optimization of alpha-ketooxazole inhibitors of fatty acid amide hydrolase. J Med Chem. 2008 Feb 28;51(4):937-47. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.